If any investor has stood the test of time, it is Warren Buffett, and with good reason. For years, the “Oracle of Omaha” has ...

Merck’s strong oncology gains, 4% yield, and low PEG ratio support its value case despite sector risks and patent concerns.

Shares of UnitedHealth Group Inc. (NYSE: UNH) climbed 2.81% in Monday's pre-market trading session, extending Friday's gain ...

UnitedHealth Group Incorporated stocks jumped sharply, riding a wave of investor enthusiasm. Berkshire Hathaway's new $1.57B ...

UnitedHealth Group Incorporated (NYSE:UNH) is one of the Oversold Fundamentally Strong Stocks to Buy Now. On August 7, Mizuho analyst Ann Hynes kept her “Buy” rating, expecting long-term value despite ...

Berkshire Hathaway recently filed its second-quarter 13F form, revealing its stock holdings at the end of June.